Purpose Our aim was to determine the transplant-free survival for pediatric hypertrophic
cardiomyopathy (HCM) patients with decreased left ventricular (LV) systolic function and …

Purpose Our objective was to provide a contemporary analysis of a pediatric hypertrophic
cardiomyopathy (HCM) cohort and determine risk factors independently associated with …

We previously reported initial results from a univariate analysis of baseline predictors of
death or heart transplant in children with hypertrophic cardiomyopathy (HCM). We present …

To date limited data are available to predict the progression to end-stage heart failure (HF)
with subsequent death (non-SCD), need for heart transplantation, or sudden cardiac death …

BACKGROUND: The development of left ventricular systolic dysfunction (LVSD) in
hypertrophic cardiomyopathy (HCM) is rare but serious and associated with poor outcomes …

BACKGROUND: The course of pediatric hypertrophic cardiomyopathy (HCM) is variable,
and the indications for heart transplantation (HTx) are ill defined. This study investigated …

Background—Population-based studies have provided insight into the natural history of
adult hypertrophic cardiomyopathy, but comparable information for affected children is …

Objectives: This study was designed to review outcomes of pediatric isolated hypertrophic
cardiomyopathy (HCM) managed uniformly at a single institution and assess whether …

Background: Hypertrophic cardiomyopathy (HCM) is associated with an increased risk of
sudden and heart failure deaths in children. A subgroup of patients (pts) with restrictive …

Background Few data on paediatric hypertrophic cardiomyopathy (HCM) are available in
developing countries. A multicentre, retrospective, cohort study was conducted to profile the …